CONSTELLIUM SE
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 3. Legal Proceedings
The Company is involved, and may become involved, in various lawsuits, claims and proceedings relating to customer
claims, product liability, employee and retiree benefit matters, and other commercial matters. The Company records provisions
for pending litigation matters when it determines that it is probable that an outflow of resources will be required to settle the
obligation, and such amounts can be reasonably estimated. In some proceedings, the issues raised are or can be highly complex
and subject to significant uncertainties and amounts claimed are and can be substantial. As a result, the probability of loss and
an estimation of damages are and can be difficult to ascertain. From time to time, asbestos-related claims are also filed against
us, relating to historic asbestos exposure in our production process. We have made reserves for potential occupational disease
claims for a total of$9 million as of December 31, 2024. It is not anticipated that any of our currently pending litigation and
proceedings will have a material effect on the future results of the Company.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.